Northern Financial Advisors Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1962457 BLOOMFIELD HILLS, MI

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,092,461

-$79,083 QoQ

Shares Held

8,647

+2.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#1,034

of 2,266 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Northern Financial Advisors Inc holds $8,250,442 across 7 Drug Manufacturers - General names. GILD ranks #4 (13.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,910	$2,290,911
2	AMGN	Amgen Inc	3,847	$1,393,075
3	JNJ	Johnson & Johnson	4,699	$1,193,405
4	GILD	Gilead Sciences, Inc. This page	8,647	$1,092,461
5	MRK	Merck & Co., Inc.	8,398	$1,079,143
6	ABBV	AbbVie Inc.	3,712	$934,087
7	PFE	Pfizer Inc	11,103	$267,360

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,092,461	8,647	+2.9%	Shares	Sole	2026-07-28
2026-03-31	$1,171,544	8,406	+86.3%	Shares	Sole	2026-04-28
2025-12-31	$553,802	4,512	-50.8%	Shares	Sole	2026-01-27
2025-09-30	$1,017,204	9,164	+0.9%	Shares	Sole	2025-11-10
2025-06-30	$1,007,143	9,084	-0.4%	Shares	Sole	2025-07-23
2025-03-31	$1,022,120	9,122	+130.2%	Shares	Sole	2025-05-06
2024-12-31	$365,969	3,962	+17.3%	Shares	Sole	2025-01-30
2024-03-31	$247,438	3,378	-15.7%	Shares	Sole	2024-04-30
2023-12-31	$324,688	4,008	+17.3%	Shares	Sole	2024-02-06
2023-09-30	$255,995	3,416	-4.2%	Shares	Sole	2023-11-14
2023-06-30	$274,908	3,567	-0.6%	Shares	Sole	2023-07-21
2023-03-31	$297,862	3,590	+24.0%	Shares	Sole	2023-04-27
2022-12-31	$248,621	2,896	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.